GlassScriptPhysician profile
Nirat Beohar
NPI 1558337329
$75,288.40
in general payments reported to CMS, 2019-2025
21 companies · $19K in 2025
The $19K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $7,243 · 2021: $7,740 · 2022: $14K · 2023: $8,803 · 2024: $4,083 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Travel and Lodging: $3,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,175.00 |
| Food and Beverage | $10,218.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Travel and Lodging | $3,531.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $21,908.13 | 2019-2022 | |
| Edwards Lifesciences Corporation | $16,445.00 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $10,354.99 | 2019-2025 | Diamondback Coronary, Triclip, Amplatzer Amulet |
| Medtronic, INC. | $10,304.75 | 2021-2025 | Ffrangio, Symplicity G3, Onyx Frontier |
| Cordis US Corp. | $9,257.76 | 2021-2024 | Emerald |
| Boston Scientific Corporation | $2,770.93 | 2019-2025 | Crossboss, Avvigo Guidance System, Sentinel |
| Shockwave Medical, INC | $1,440.47 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $632.67 | 2020-2025 | Gore Cardioform Septal Occluder |
| Abiomed | $446.58 | 2023-2025 | Impella |
| Medtronic Vascular, INC. | $383.36 | 2019-2020 | |
| Recor Medical INC | $321.29 | 2025 | Paradise Ultrasound Renal Denervation System |
| Astellas Pharma US INC | $289.34 | 2019-2021 | |
| Penumbra, INC. | $227.49 | 2021-2025 | Penumbra System |
| Zoll Circulation INC | $173.34 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Angiodynamics, INC. | $79.00 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $59.36 | 2019 | |
| Irhythm Technologies, INC. | $56.83 | 2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $50.95 | 2024-2025 | |
| Bridgebio Pharma, INC. | $32.82 | 2025 | Attruby |
| Davol INC. | $32.39 | 2025 | Arista |
| E.R. Squibb & Sons, L.L.C. | $20.95 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirat Beohar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.